14/06/2022 Semorinemab does not slow clinical progression of AD, according to results of Tauriel clinical trial published in JAMA Neurology Science watch
13/06/2022 Financial altruism shows possible link to cognitive profile of early Alzheimer's disease Science watch
08/06/2022 Biogen withdraws application for aducanumab from Swiss licensing and supervisory authority Science watch
02/06/2022 Project Alzheimer’s Value Europe study could help prepare healthcare systems for 416 million people at risk of developing Alzheimer’s disease Science watch
02/06/2022 Research study reveals the link between early-appearing lysosome pH deficits and extracellular amyloid deposits in AD mouse models Science watch
25/05/2022 New research shows that seven healthy habits and lifestyle factors may reduce dementia risk Science watch
24/05/2022 New research identifies FMNL2 as a potential genetic link between Alzheimer’s and vascular disease Science watch
23/05/2022 Alzheimer’s disease in people with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms Science watch
15/05/2022 It has been 20 years since the last approval of an Alzheimer’s medication in Europe Science watch
13/05/2022 Green Valley announces early termination of Phase III drug trial, citing funding concerns and practical issues caused by the COVID-19 pandemic Science watch
